This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.
| Device | P030029S002 |
| Classification Name | None |
| Applicant | |
| PMA | P030029 |
| Supplement | S002 |
| Supplement Number | Date | Supplement Type |
|---|---|---|
| P030029 | Original Filing | |
| S013 | 2012-03-26 | Normal 180 Day Track No User Fee |
| S012 | 2011-02-16 | 30-day Notice |
| S011 | 2010-09-29 | 30-day Notice |
| S010 | ||
| S009 | 2009-09-28 | Normal 180 Day Track |
| S008 | 2009-08-21 | 30-day Notice |
| S007 | 2009-05-18 | Normal 180 Day Track |
| S006 | 2009-03-31 | Normal 180 Day Track |
| S005 | 2009-03-03 | Normal 180 Day Track No User Fee |
| S004 | 2008-09-18 | Normal 180 Day Track |
| S003 | 2008-08-11 | Normal 180 Day Track |
| S002 | ||
| S001 | 2007-03-14 | 135 Review Track For 30-day Notice |
| Device ID | PMA | Supp |
|---|---|---|
| 00630414471860 | P030029 | 000 |
| 00630414471914 | P030029 | 003 |